Skip to main content
Fig. 1 | Journal of Inflammation

Fig. 1

From: Src kinase inhibition with dasatinib impairs neutrophil function and clearance of Escherichia coli infection in a murine model of acute lung injury

Fig. 1

Effect of dasatinib pre-treatment on E. coli presence and survival in a, BAL fluid, b, lung homogenates, c, spleen, d, liver and e, peripheral blood from mice exposed to i.t. E. coli. *p < 0.05, ***p < 0.001. Values were derived from two experiments (1 mg/kg or 10 mg/kg dasatinib vs. control administered at 0 and 12 h) using 8 mice per group. DAS = dasatinib

Back to article page